May 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its consolidated net profit fell to 12.3 million levs ($7.3 million/6.3 million euro) in the first quarter of 2018 from 17.0 million levs in the like period of last year.